Results 201 to 210 of about 46,312 (227)

Real-time detection and differentiation of direct oral anticoagulants (rivaroxaban and dabigatran) using modified thromboelastometric reagents.

Thrombosis Research, 2020
INTRODUCTION Timely measurement of direct oral anticoagulants (DOACs) is challenging, though clinically important. We tested the hypotheses, that thromboelastometry is able to detect dabigatran and rivaroxaban and discriminates between dabigatran and ...
S. Schäfer, Tobias Wiederkehr, T. Kammerer, Alice-Christin Acevedo, Katharina Feil, Lars Kellert, Klaus Görlinger, Ludwig C Hinske, P. Groene   +8 more
semanticscholar   +1 more source

Dabigatran/Dabigatran etexilate

Drugs of the Future, 2005
null Sorbera, L.A., null Bozzo, J., null Castaner, J.   +2 more
openaire   +1 more source

Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity

Thrombosis and Haemostasis, 2010
J. Ryn, J. Stangier, S. Haertter, Karl‐Heinz Liesenfeld, W. Wienen, M. Feuring, A. Clemens   +6 more
semanticscholar   +1 more source

Dabigatran

Practical Diabetes, 2012
Liesl Currie, Gerry McKay, Miles Fisher
openaire   +1 more source

Dabigatran: laboratory monitoring

Pathology, 2012
Simon D F, Jones, Nicola S, Eaddy, George T C, Chan   +2 more
openaire   +2 more sources

Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran

Advances in Therapy, 2020
P. Zubiaur, M. Saiz-Rodríguez, D. Ochoa, M. Navares-Gómez, G. Mejía, M. Román, D. Koller, Paula Soria-Chacartegui, Susana Almenara, F. Abad‐Santos   +9 more
semanticscholar   +1 more source

Dabigatran

Reactions Weekly, 2017
openaire   +2 more sources

Dabigatran etexilate

Reactions Weekly, 2018
  +5 more sources

Dabigatran

2015
openaire   +2 more sources

Dabigatran-etexilate

Reactions Weekly, 2020
openaire   +2 more sources